Medication info

Ogmenex Syrup [Amoxicillin-Clavulanate Potassium (14:1)]

Prescription medicationSyrupOralExpired
Ingredient · strength
Amoxicillin Hydrate›54.55g / 100gDilute Potassium Clavulanate›3.9g / 100g
Manufacturer / importer
Hanpoong Pharmaceutical Co., Ltd.
Appearance
A white to light yellowish powder with a peculiar smell, used as a syrup that is reconstituted before use.
Packaging
50 milliliters/bottle
Approval status
Expired

MFDS item code 201904490 · Notified 2019.07.01

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute rhinosinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Caution should be exercised when administering this drug to patients with hepatic impairment, and liver function should be monitored regularly. ○ To minimize the possibility of gastrointestinal disturbances, this drug should be administered at the start of a meal. Administration of this drug at the start of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients aged 3 months and older: The recommended dose of this drug is 90mg/kg/day, based on the amoxicillin content (600 mg/5 mL), divided into doses every 12 hours. Administer for 10 days for acute otitis media and 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute rhinosinusitis in children

  • Recurrent acute otitis media
  • persistent acute otitis media
  • recurrent acute sinusitis
View approved original text

This medication is effective against bacteria such as Streptococcus pneumoniae, Haemophilus influenzae (including beta-lactamase producing strains), and Moraxella catarrhalis (including beta-lactamase producing strains). It is used when acute otitis media or acute sinusitis recurs or persists in pediatric patients. However, these patients must have a history of antibiotic treatment for these conditions within the last 3 months, be under 2 years old, or attend daycare. This medication helps treat acute otitis media and acute sinusitis in children with these risk factors.

How to take

Adult dose

○ Adults: There is no experience with the use of this drug in adults. ○ Patients with hepatic impairment: Caution should be exercised when administering this drug to patients with hepatic impairment, and liver function should be monitored regularly. ○ To minimize the possibility of gastrointestinal disturbances, this drug should be administered at the start of a meal. Administration of this drug at the start of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients aged 3 months and older: The recommended dose of this drug is 90mg/kg/day, based on the amoxicillin content (600 mg/5 mL), divided into doses every 12 hours. Administer for 10 days for acute otitis media and 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this drug in pediatric patients weighing 40kg or more.

Precautions

This medication contains the artificial sweetener aspartame, which should not be taken by patients with the hereditary condition phenylketonuria. The daily intake of aspartame contained in this medication is regulated not to exceed the WHO recommended limits, so care should be taken not to exceed the recommended dose. Patients who have had hypersensitivity reactions to any of the ingredients in this medication or to beta-lactam antibiotics, patients with infectious mononucleosis or lymphocytic leukemia, or those who have previously experienced liver dysfunction or jaundice due to this medication should not take this drug. Additionally, patients with genetic conditions such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not use this medication. Patients with impaired liver function or severe kidney disease should use this medication with caution, and dosing intervals may need to be adjusted. Patients with allergies or symptoms such as bronchial asthma, skin rashes, or urticaria should also be cautious. Patients who cannot take medication orally, elderly patients, and those in poor overall health should be careful as symptoms of vitamin K deficiency may occur. Patients with gastrointestinal conditions causing vomiting or diarrhea may not properly absorb the medication, so be cautious. This medication is generally safe, but common side effects may include diarrhea, vomiting, skin rash, contact dermatitis, and more. If symptoms are severe, discontinuation of the medication should be considered. Rare side effects such as liver dysfunction, severe allergic reactions, blood disorders, and kidney issues have also been reported, so immediate consultation with a doctor is necessary if abnormal symptoms occur. This medication should only be taken for the necessary duration to prevent the development of resistant bacteria, and should not be stopped or dosage adjusted arbitrarily. Patients who have had hypersensitivity reactions to penicillin antibiotics should inform healthcare providers before taking this medication. This medication should not be used during the first 3 months of pregnancy, and breastfeeding mothers should be cautious as side effects may occur in the baby. Safety has not been established in infants under 3 months of age, so it should not be used in this group. This medication may interact with other drugs, so be sure to inform healthcare providers of any other medications being taken. In case of overdose, gastrointestinal symptoms, kidney damage, or seizures may occur, and immediate medical assistance should be sought while ensuring adequate hydration. This medication should be well shaken before use, and should be stored in the refrigerator after preparation and used within 7 days. Keep out of reach of children and store in a dry place at a temperature below 25 degrees Celsius.

Side effects

  • Contact dermatitis
  • diarrhea
  • vomiting
  • moniliasis
  • rash
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
Show 85 more
  • black hairy tongue
  • nausea
  • anorexia
  • abdominal pain
  • abdominal distension
  • constipation
  • colonic pain
  • hyperacidity
  • melena
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • elevated AST
  • elevated ALT
  • elevated ALP
  • elevated LDH
  • elevated serum bilirubin
  • hepatitis
  • cholestatic jaundice
  • itching
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular dermatosis
  • eosinophilia
  • drug reaction (DRESS)
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • reversible thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning sensation
  • increased secretion
  • agitation
  • anxiety
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • seizures
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • vitamin K deficiency symptoms
  • vitamin B complex deficiency symptoms
  • tooth discoloration
  • linear IgA disease
  • dysgeusia
  • malaise
  • dermatitis
  • oral swelling
  • stomach pain
  • fluid and electrolyte imbalance
  • hyperactivity
  • drowsiness
  • interstitial nephritis
  • acute renal failure due to hyperglycemia
  • hypersensitivity shock
  • skin reactions
  • bleeding
  • pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering. Additionally, it is recommended to place it in a dry area with a temperature between 1 degree and 25 degrees. Storing it this way helps maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

A white to light yellowish powder with a peculiar smell, used as a syrup that is reconstituted before use.

Package unit

50 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.